Manodeep Sen

Dr. Manodeep Sen


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
TCTanushri Chatterji
Tanushri Chatterji
NKNamrata Khanna
Namrata Khanna
Saad Saeed AlghamdiSaad Saeed Alghamdi
Saad Saeed Alghamdi
TBTanya Bhagat
Tanya Bhagat
NGNishant Gupta
Nishant Gupta
Virendra Kumar YadavVirendra Kumar Yadav
Virendra Kumar Yadav
Schistosomiasis, which affects a large number of people worldwide, is among the most overlooked parasitic diseases. The disease is mainly prevalent in sub-Saharan Africa, southeast Asian countries, and South America due to the lack of adequate sanitation. The disease is mainly associated with poor hygiene, sanitation, and contaminated water, so it is also known as a disease of poverty. Three Schistosoma species (S. mansoni, S. japonicum, and S. haematobium) cause significant human infections. Co-infections with Schistosoma and other parasites are widely common. All these parasites may cause intestinal or urogenital schistosomiasis, where the disease may be categorized into the acute, sensitized, and chronic phases. The disease is more prevalent among school children, which may cause anemia and reduce development. Chronic infections frequently cause significant liver, intestinal, and bladder damage. Women exposed to contaminated water while performing normal duties like washing clothes might acquire urogenital schistosomiasis (UGS), which can cause tissue damage and raise the risk of blood-borne disease transmission, including human immunodeficiency virus (HIV) transmission. Praziquantel (PZQ) is the World Health Organization (WHO)-prescribed treatment for individuals who are known to be infected, but it does not prevent further re-infections with larval worms. Vaccine development and new molecular-based diagnosis techniques have promised to be a reliable approach to the diagnosis and prevention of schistosomiasis. The current review emphasizes the recent advancement in the diagnosis of schistosomiasis by molecular techniques and the treatment of schistosomiasis by combined and alternative regimes of drugs. Moreover, this review has also focused on the recent outbreak of schistosomiasis, the development of vaccines, and their clinical trials.

1 January 2016 in Clinica Chimica Acta
Verified
Journal Article
Closed access
SSSuruchi Singh
Suruchi Singh
TCTanushri Chatterji
Tanushri Chatterji
MSManodeep Sen
Manodeep Sen
IDIshwar Ram Dhayal
Ishwar Ram Dhayal
SMSwati Mishra
Swati Mishra
RRRaja Roy
Raja Roy

1 June 2021 in Indian Journal of Critical Care Medicine
Verified
Journal Article
Open access
RKRajeev Kumar
Rajeev Kumar
MSManodeep Sen
Manodeep Sen
ADAnupam Das
Anupam Das
JAJyotsna Agarwal
Jyotsna Agarwal
SNSoumya S Nath
Soumya S Nath
VSVikramjeet Singh
Vikramjeet Singh
Increasing antimicrobial resistance (AMR) among common bacteria combined with the slow development of new antibiotics has posed a challenge to clinicians. To demonstrate whether antimicrobial and diagnostic stewardship program (ASP and DSP)-related interventions improve antibiotic susceptibilities among common bacteria causing bloodstream infections (BSI) in patients admitted to the intensive care unit (ICU) and whether these resulted in changes in the volume of antimicrobial consumption. We compared the susceptibility patterns of gram-negative bacteria (GNB) and gram-positive cocci (GPC) causing BSI and changes in the volume of antibiotics prescribed for the same before and after 2017 by a retrospective analysis. Postintervention, there was increased susceptibility of all GNBs to aminoglycosides; Escherichia coli and Klebsiella spp. to beta-lactambeta-lactamase inhibitors (BLBLI) combinations; and Klebsiella spp. and Pseudomonas spp. to carbapenems. Acinetobacter spp., Klebsiella spp., and Pseudomonas spp. showed improved susceptibility to doxycycline, whereas E. coli and Klebsiella spp. showed significantly improved susceptibility to fluoroquinolones. Among GPCs, there was increased susceptibility of Staphylococcus aureus (levofloxacin, clindamycin, and aminoglycoside), coagulase-negative S. aureus (CoNS) (chloramphenicol, levofloxacin, clindamycin, and aminoglycoside), and enterococci (chloramphenicol, levofloxacin, and clindamycin). There was a significant reduction in usage of antimicrobials for the treatment of GPCs (linezolid, doxycycline, chloramphenicol, levofloxacin, BLBLI, macrolide, and cephalosporin) and GNBs (levofloxacin, cephalosporin, carbapenem, and colistin), which caused BSI. The present study illustrated that combined ASP and DSP interventions successfully reversed the resistance pattern of organisms causing BSI and resulted in a reduction in antibiotic utilization. Agarwal J, Singh V, Das A, Nath SS, Kumar R, Sen M. Reversing the Trend of Antimicrobial Resistance in ICU: Role of Antimicrobial and Diagnostic Stewardship. Indian J Crit Care Med 2021;25(6):635–641.

1 June 2017 in Clinica Chimica Acta
Verified
Journal Article
Closed access
TCTanushri Chatterji
Tanushri Chatterji
SSSuruchi Singh
Suruchi Singh
MSManodeep Sen
Manodeep Sen
ASAjai Kumar Singh
Ajai Kumar Singh
GAGaurav Raj Agarwal
Gaurav Raj Agarwal
RRRaja Roy
Raja Roy

14 July 2016 in Metabolomics
Verified
Journal Article
Closed access
PDF file
TCTanushri Chatterji
Tanushri Chatterji
SSSuruchi Singh
Suruchi Singh
MSManodeep Sen
Manodeep Sen
ASAjai Kumar Singh
Ajai Kumar Singh
PMPradeep Kumar Maurya
Pradeep Kumar Maurya
RRRaja Roy
Raja Roy

1 January 2019 in MGM Journal of Medical Sciences
Verified
Journal Article
Open access
MSManodeep Sen
Manodeep Sen
SISana Islahi
Sana Islahi
ADAnupam Das
Anupam Das
AGAkansha Gupta
Akansha Gupta
STShalini Trivedi
Shalini Trivedi
JAJyotsna Agarwal
Jyotsna Agarwal
In intensive care unit having postviral encephalopathy with cerebral palsy. It is a unique case because we could not find any prior published case report of B. bronchiseptica associated with wound infection in humans. B. bronchiseptica can be a cause of wound infection in humans. In severely immunocompromised patients, this rare organism can become an opportunistic pathogen to cause severe wound infections and medical microbiologists should keep themselves updated in diagnosing such isolates and clinicians should be mindful of their diverse clinical manifestations and limited treatment options....